Ibogaine-associated ventricular tachyarrhythmias

Ales PleskovicUniversity Medical Centre Ljubljana, Medical Intensive Care Unit, Ljubljana Gordana Kozelj Medical Faculty, Institute of Forensic Medicine,Ljubljana Miran Brvar University Medical Centre, Ljubljana, Poison Control Centre, Ljubljana, SloveniaCorrespondence[email protected]

, MD,

Vojka GorjupUniversity Medical Centre Ljubljana, Medical Intensive Care Unit, Ljubljana Gordana Kozelj Medical Faculty, Institute of Forensic Medicine,Ljubljana Miran Brvar University Medical Centre, Ljubljana, Poison Control Centre, Ljubljana, Slovenia

M. BrvarUniversity Medical Centre Ljubljana, Medical Intensive Care Unit, Ljubljana Gordana Kozelj Medical Faculty, Institute of Forensic Medicine,Ljubljana Miran Brvar University Medical Centre, Ljubljana, Poison Control Centre, Ljubljana, Slovenia

G. KozeljUniversity Medical Centre Ljubljana, Medical Intensive Care Unit, Ljubljana Gordana Kozelj Medical Faculty, Institute of Forensic Medicine,Ljubljana Miran Brvar University Medical Centre, Ljubljana, Poison Control Centre, Ljubljana, Slovenia

References

Hoelen D, Spiering W, Valk G. Long-QT syndrome induced by the antiaddiction drug ibogaine. N Engl J Med 2009; 360:308–309.
PubMed Web of Science ®Google Scholar
Maas U, Strubelt S. Fatalities after taking ibogaine in addiction treatment could be related to sudden cardiac death caused by autonomic dysfunction. Med Hypotheses 2006; 67:960–964.
PubMed Web of Science ®Google Scholar
Voigt L, Coromilas J, Saul BI, Kassotis J. Amiodarone-induced torsade de pointes during bladder irrigation: an unusual presentation-a case report. Angiology 2003; 54:229–231.
PubMed Web of Science ®Google Scholar
Martins JB, Zipes DP, Lund DD. Distribution of local repolarization changes produced by efferent vagal stimulation in the canine ventricles. J Am Coll Cardiol 1983; 2:1191–1199.
PubMed Web of Science ®Google Scholar
Mash DC, Kovera CA, Pablo J, Tyndale RF, Ervin FD, Williams IC, Singleton EG, Mayor M: Ibogaine: complex pharmacokinetics, concerns for safety, and preliminary efficacy measures. Ann N Y Acad Sci 2000; 914:394–401.
PubMed Web of Science ®Google Scholar

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Ibogaine-associated ventricular tachyarrhythmias

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Ibogaine-associated ventricular tachyarrhythmias

References

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date